Tatva Chintan Pharma Chem Limited (TATVA.NS)
INR 730.0
(-4.05%)
INR 730.0
(-4.05%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 13.26 INR | -35.38% |
| 2022 | 20.52 INR | -53.98% |
| 2021 | 44.59 INR | 71.37% |
| 2020 | 26.02 INR | 38.33% |
| 2019 | 18.81 INR | 83.87% |
| 2018 | 10.23 INR | 67.16% |
| 2017 | 6.12 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.29 INR | -113.0% |
| 2024 Q1 | 2.23 INR | -45.74% |
| 2023 Q1 | 4.29 INR | -43.92% |
| 2023 Q2 | 3.43 INR | -20.05% |
| 2023 FY | - INR | -35.38% |
| 2023 Q4 | 4.11 INR | 177.7% |
| 2023 Q3 | 1.48 INR | -56.85% |
| 2022 FY | - INR | -53.98% |
| 2022 Q4 | 7.65 INR | 45.99% |
| 2022 Q3 | 5.24 INR | 63.24% |
| 2022 Q2 | 3.21 INR | -27.38% |
| 2022 Q1 | 4.42 INR | -44.05% |
| 2021 Q1 | 10.44 INR | -0.67% |
| 2021 FY | - INR | 71.37% |
| 2021 Q4 | 7.90 INR | -23.23% |
| 2021 Q3 | 10.29 INR | -31.49% |
| 2021 Q2 | 15.02 INR | 43.87% |
| 2020 Q3 | 10.39 INR | 487.01% |
| 2020 Q2 | 1.77 INR | -47.01% |
| 2020 Q1 | 3.34 INR | 0.0% |
| 2020 FY | - INR | 38.33% |
| 2020 Q4 | 10.51 INR | 1.15% |
| 2019 FY | - INR | 83.87% |
| 2018 FY | - INR | 67.16% |
| 2017 FY | - INR | 0.0% |